PCP Clinical Tools

Identify Best Practices for Assessing and Screening for T2DM

Clinical tools were developed with direction from a Clinical Advisory Panel and contain guidance on best practices for assessing and screening women of child-bearing age at high risk for developing T2DM.

Recommended T2DM screening frequency

Determine if your patient has a history of Gestational Diabetes Mellitus (GDM), and when a T2DM screening was completed. If the most recent results are in range for:

Normal: Re-screen every 1 to 3 years depending on specific risk factors

Prediabetes: Re-screen annually

Diabetes: Start diabetes management protocol, which typically includes A1c screenings every 3-6 months

GDM: Screen at 4-12 weeks postpartum, then re-screen as indicated above based on the results.

Postpartum Screening for T2DM:

If a woman is in her immediate postpartum phase, within 12 weeks of delivery, the American College of Obstetricians and Gynecologists (ACOG) recommends that a fasting plasma glucose test or a 2-hour, 75-g oral glucose tolerance test be performed. In addition, ongoing screenings for diabetes everything 3 years should occur for those with a normal result.